Inspiremd Stock Probability of Future Stock Price Finishing Under 2.81

NSPR Stock  USD 2.92  0.10  3.31%   
InspireMD's future price is the expected price of InspireMD instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of InspireMD performance during a given time horizon utilizing its historical volatility. Check out InspireMD Backtesting, InspireMD Valuation, InspireMD Correlation, InspireMD Hype Analysis, InspireMD Volatility, InspireMD History as well as InspireMD Performance.
To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.
  
At this time, InspireMD's Price Book Value Ratio is relatively stable compared to the past year. As of 11/29/2024, Price Earnings To Growth Ratio is likely to grow to 0.06, while Price Earnings Ratio is likely to drop (3.60). Please specify InspireMD's target price for which you would like InspireMD odds to be computed.

InspireMD Target Price Odds to finish below 2.81

The tendency of InspireMD Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 2.81  or more in 90 days
 2.92 90 days 2.81 
about 89.64
Based on a normal probability distribution, the odds of InspireMD to drop to $ 2.81  or more in 90 days from now is about 89.64 (This InspireMD probability density function shows the probability of InspireMD Stock to fall within a particular range of prices over 90 days) . Probability of InspireMD price to stay between $ 2.81  and its current price of $2.92 at the end of the 90-day period is about 7.99 .
Given the investment horizon of 90 days InspireMD has a beta of 0.42. This indicates as returns on the market go up, InspireMD average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding InspireMD will be expected to be much smaller as well. Additionally InspireMD has an alpha of 0.0213, implying that it can generate a 0.0213 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   InspireMD Price Density   
       Price  

Predictive Modules for InspireMD

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as InspireMD. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.022.915.80
Details
Intrinsic
Valuation
LowRealHigh
0.453.346.23
Details
1 Analysts
Consensus
LowTargetHigh
3.964.354.83
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.2-0.2-0.2
Details

InspireMD Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. InspireMD is not an exception. The market had few large corrections towards the InspireMD's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold InspireMD, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of InspireMD within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.02
β
Beta against Dow Jones0.42
σ
Overall volatility
0.15
Ir
Information ratio -0.02

InspireMD Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of InspireMD for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for InspireMD can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
The company reported the previous year's revenue of 6.21 M. Net Loss for the year was (19.92 M) with profit before overhead, payroll, taxes, and interest of 1.12 M.
InspireMD currently holds about 26.47 M in cash with (16.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
InspireMD has a frail financial position based on the latest SEC disclosures
Roughly 17.0% of the company outstanding shares are owned by corporate insiders
Latest headline from thelincolnianonline.com: InspireMD Appoints Scott R. Ward to Board of Directors

InspireMD Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of InspireMD Stock often depends not only on the future outlook of the current and potential InspireMD's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. InspireMD's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding24.3 M
Cash And Short Term Investments39 M

InspireMD Technical Analysis

InspireMD's future price can be derived by breaking down and analyzing its technical indicators over time. InspireMD Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of InspireMD. In general, you should focus on analyzing InspireMD Stock price patterns and their correlations with different microeconomic environments and drivers.

InspireMD Predictive Forecast Models

InspireMD's time-series forecasting models is one of many InspireMD's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary InspireMD's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about InspireMD

Checking the ongoing alerts about InspireMD for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for InspireMD help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company reported the previous year's revenue of 6.21 M. Net Loss for the year was (19.92 M) with profit before overhead, payroll, taxes, and interest of 1.12 M.
InspireMD currently holds about 26.47 M in cash with (16.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
InspireMD has a frail financial position based on the latest SEC disclosures
Roughly 17.0% of the company outstanding shares are owned by corporate insiders
Latest headline from thelincolnianonline.com: InspireMD Appoints Scott R. Ward to Board of Directors

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.